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Hippocampal dentate granule cell abnormalities are thought to play a causative role in temporal lobe
epilepsy, but their precise contribution has not been dissociated from coexisting pathological changes. In
this issue of Neuron, Pun et al. (2012) show, for the first time, that inducing proexcitatory changes in a subset
of DGCs in isolation is sufficient to cause epilepsy in a rodent.The epilepsies are a diverse group of
disorders in which seizures are the
defining manifestation. Seizure initiation
and spread in temporal lobe epilepsy
(TLE), one of the most common and
intractable epilepsies in adolescents and
adults, is thought to involve medial
temporal structures, such as the hippo-
campus, parahippocampal regions, and
amygdala. These regions often display
distinct histopathology, the hallmark of
which is Ammon’s horn sclerosis (AHS).
AHS is characterized by pronounced
pyramidal and hilar neuronal cell death,
astrogliosis, and proexcitatory reorgani-
zation of dentate granule cells (DGCs).
The dentate gyrus typically acts as a
‘‘gate’’ for excitatory input to the hippo-
campus, and accumulating evidence
suggests that DGC reorganization in ex-
perimental TLE breaks down this gating
function (Pathak et al., 2007). As a result,
DGC structural remodeling is hypothe-
sized to be pro-epileptogenic.Under normal conditions, DGCs re-
ceive strong feedforward and feedback
inhibition and do not synapse onto one
another. Their somas reside in the granule
cell layer and they extend apical dendrites
into themolecular layer and axons into the
hilus and statum lucidum of area CA3
(Figure 1A). DGCs synapse onto mossy
cells and inhibitory interneurons in the
hilus, and onto pyramidal cells in CA3. In
human and experimental TLE, DGC
somas may enlarge, some are found
ectopically in the hilus and molecular
layer, a subset display basal dendrites
extending abnormally into the hilus, and
DGC axon collaterals sprout into the inner
molecular layer (Figure 1B), a process
known as mossy fiber sprouting. These
changes are associated with increased
excitatory input and aberrant DGC inter-
connectivity (Parent, 2007) and are
believed to promote hypersynchronous
spread of excitation through the hippo-
campus. Recent work also implicatesaltered adult DGC neurogenesis in exper-
imental TLE (Jessberger et al., 2007; Kron
et al., 2010; Parent et al., 2006; Walter
et al., 2007). DGCs that develop during
or after an epileptogenic insult appear to
be most susceptible to aberrant integra-
tion that may cause hyperexcitability
(Jessberger et al., 2007; Kron et al.,
2010; Walter et al., 2007), and suppress-
ing adult neurogenesis variably attenu-
ates the seizure phenotype in rodent
models of TLE (Jung et al., 2004). In
contrast, normally integrated, adult-
generated DGCs may play an anti-epilep-
togenic role (Jakubs et al., 2006). To
date, it has been difficult to distinguish
between changes that are pathological
and those that are not functionally rele-
vant or perhaps even homeostatic in TLE.
In this issue, Pun et al. (2012) induce
abnormal integration of DGCs in relative
isolation to determine whether this is
sufficient to cause epilepsy. To accom-
plish this, they conditionally ablate the
Figure 1. Schematics of DGC Morphological Changes with Experimental TLE and Pten Conditional Knockout
(A) Normally, adult-generated DGCs develop to become morphologically indistinguishable from perinatally generated DGCs.
(B) In rodent TLEmodels, DGCs developing during or after epileptogenic insults displaymultiple structural abnormalities. Pre-existing, mature DGCs are relatively
resistant, but may participate in mossy fiber sprouting.
(C) DGCs that lack PTEN display TLE-like aberrant morphology leading to epilepsy and also mossy fiber sprouting by genetically normal DGCs. GCL, granule cell
layer; IML, inner molecular layer.
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generated DGCs and thereby dissociate
several DGC pathologies from other
aspects of AHS such as cell death, astro-
gliosis, and inflammation. This approach
allows the potential epileptogenic conse-
quences of DGC pathology to be tested
directly. PTEN is an upstream inhibitor of
mammalian target of rapamycin (mTOR),
which is upregulated during epileptogen-
esis in experimental and human TLE,
and in a variety of human developmental
epilepsies (Russo et al., 2012). Moreover,
this pathway is implicated in the develop-
ment of mossy fiber sprouting in TLE
models (Zeng et al., 2009, Buckmaster
and Lew, 2011), and conditional Pten
deletion in mice alters DGC neurogenesis
and induces seizures (Amiri et al., 2012).
To selectively ablate Pten in DGCs, Pun
et al. (2012) crossed a Gli1-CreERT2
mouse line with floxed Pten and GFP
recombination reporter mice. Because
the hippocampal dentate gyrus is one of
the few adult brain regions wherein neural
progenitors persist postnatally, tamoxifen
treatment of the mice beginning at
postnatal day 14, along with inefficient
Cre-mediated recombination, enabled
relatively specific Pten knockout in a
minority of DGCs. They found that loss
of PTEN and the subsequent increase
in mTOR signaling induced profound
abnormalities in DGC morphology that
recapitulate those seen in TLE. Affected
DGCs displayed neuronal hypertrophy,abnormal basal dendrites, dramatically
increased dendritic spine density, and
ectopic locations (Figure 1C). In 82% of
animals, Pten deletion led to spontaneous
seizures beginning as early as 4 weeks
after tamoxifen treatment and increasing
in severity over time. By correlating the
degree of recombination with the pres-
ence of an epilepsy phenotype, they
observed that Pten deletion in as few as
9% of DGCs was sufficient to induce
epilepsy.
Because Gli1 is expressed in subgranu-
lar and subventricular zone neural pro-
genitors, as well as in subsets of glia, it
was important to exclude these as a
source of epileptogenic plasticity. No
morphological changes were observed
in the very small subset of glia (less than
3% in the densest region) that underwent
recombination. In addition, alterations
due to Pten deletion were much less
robust in the olfactory bulb than the den-
tate gyrus. More importantly, Pun et al.
(2012) recorded EEG simultaneously
from the hippocampus and olfactory
bulb and found that seizure onsets
occurred in the hippocampus without
any corresponding activity in the bulb.
They also confirmed that the patholog-
ical effects of Pten deletion were medi-
ated via mTOR activation by blocking
them with rapamycin, an mTOR inhibitor.
Rapamycin treatment prevented epilepsy
development in three animals and de-
creased seizure frequency by more thanNeuron 75, Seten-fold in two others. The treatment
also abolished mossy fiber sprouting,
but the importance of this effect for atten-
uating seizures is uncertain given that
others have found rapamycin treatment
produces transitory effects, and the
degree of sprouting does not correlate
well with seizure reduction (Buckmaster
and Lew, 2011). Interestingly, Pun et al.
(2012) found that some DGCs that sprout
do not show evidence of recombination,
suggesting that mossy fiber sprouting
may be a consequence of seizures, rather
than a cause.
The proximate cause of epilepsy in this
model is, of course, the elimination of
PTEN from a subset of postnatally gener-
ated neurons. Although this induces pro-
found abnormalities in a minority of
DGCs, it is not clear how these abnormal-
ities specifically relate to epileptogenesis.
DGC morphological changes are con-
sistent with increased excitatory input,
especially from other DGCs, including
the de novo presence of hilar basal den-
drites, ectopic migration, and increased
dendritic spine density. Finding that these
changes need occur in only 9% of DGCs
to produce epilepsy is remarkable, but,
perhaps, not unexpected. In an elegant
computational study, Morgan and Soltesz
showed that a small subset (as little as
5%) of hyperinnervated ‘‘hub’’ DGCs, in
the context of an otherwise normally con-
nected network, results in the ability of
seizure-like activity to spread easilyptember 20, 2012 ª2012 Elsevier Inc. 939
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Previewsand rapidly throughout the network
(Morgan and Soltesz, 2008). Although
Pun et al. (2012) show that altered
mTOR signaling-induced DGC abnormal-
ities are sufficient to produce epilepsy,
it remains to be determined whether
they are necessary for TLE develop-
ment. Nonetheless, this work establishes
a strong link between relatively isolated
DGC pathology and subsequent epilepsy
that warrants further attention directed
toward a long-sought anti-epileptogenic
therapy.
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In this issue of Neuron, Li et al. (2012) show that the neuron/glia cell fate switch of cortical progenitors is
regulated by MEK1 and MEK2. The observations resonate with recent studies on the genesis of low-grade
astrocytomas and highlight neuronal support functions of astrocytes in the postnatal brain.In what seems like a case of ‘‘unintelligent
design,’’ a wide range of growth factors
and other biological response modifiers
signal from the outer cell surface to the
nucleus through a device that hasminimal
functional redundancy. In the ‘‘classic’’
version of the RAF/MEK/ERK signaling
cascade (Figure 1), signaling from some
90 odd receptor and nonreceptor tyrosine
kinases (Robinson et al., 2000) is chan-
neled initially through a set of just three
small guanosine triphosphate (GTP)-
binding RAS proteins (Barbacid, 1987;
McCormick, 1993). Information from
RAS flows next to a set of three RAF family
serine/threonine kinases and thence to
themixed function protein kinases (mean-
ing they are capable of phosphorylating
either threonine or tyrosine residues)MEK1 and MEK2. The terminal kinases
in this signaling axis, ERK1 and ERK2,
require phosphorylation of a critical
threonine x tyrosine motif to become
activated. As mixed function protein
kinases, MEK1 and MEK2 are the sole
practitioners of ERK activation. Activated
ERKs move from cytosol into the nucleus
and mark the transition from cytoplasmic
to nuclear signaling (McKay andMorrison,
2007). A wide range of ERK-modulated
transcription factors and ‘‘immediate
early’’ genes regulate fundamental as-
pects of cell biology including prolifera-
tion, differentiation, survival, and motility.
Against this backdrop, one might
imagine that targeted ablation of MEK1
and MEK2 would shut down a signaling
pathway for multiple growth factors andhave devastating consequences for cell
growth and survival. However, in this issue
ofNeuron, Li et al. (2012) report a far more
nuanced and interesting phenotype when
Mek1 and Mek2 are ablated in cortical
progenitors of developing mice. The point
of departure for Li et al. (2012) is a labor-
intensive set of intercrosses between
a Mek2 knockout mouse strain (notably
viable and fertile) and a Mek1 floxed
mouse line. By intercrossing the Mek1
floxed and Mek2 null responder mice
with cell type-specific Cre driver mice, Li
et al. (2012) were able to generate animals
in which the copy number of either or both
Meks could be represented at wild-type
(WT), heterozyote, or null levels.
In initial studies, a NestinCre driver
mouse line was used to ablate floxed
